GSK plc

NYSE:GSK Stock Report

Market Cap: US$69.5b

GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSE:GSK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Sep 24BuyUS$31,702Vishal SikkaIndividual773US$41.01
23 Sep 24BuyUS$9,187Hal BarronIndividual224US$41.01
23 Sep 24BuyUS$9,187Harry DietzIndividual224US$41.01
23 Sep 24BuyUS$9,187Anne BealIndividual224US$41.01
23 Sep 24BuyUS$73,862Charles BancroftIndividual1,801US$41.01
23 Sep 24BuyUS$9,187Tsun-Huei LeeIndividual224US$41.01
23 Sep 24BuyUS$9,146Elizabeth AndersonIndividual223US$41.01
23 Sep 24BuyUS$9,187Jesse GoodmanIndividual224US$41.01
20 Jun 24BuyUS$48,062Vishal SikkaIndividual1,179US$40.76
20 Jun 24BuyUS$9,131Hal BarronIndividual224US$40.76
20 Jun 24BuyUS$9,172Harry DietzIndividual225US$40.76
20 Jun 24BuyUS$9,172Anne BealIndividual225US$40.76
20 Jun 24BuyUS$73,825Charles BancroftIndividual1,811US$40.76
20 Jun 24BuyUS$9,172Elizabeth AndersonIndividual225US$40.76
20 Jun 24BuyUS$9,172Jesse GoodmanIndividual225US$40.76
20 Dec 23BuyUS$26,619Vishal SikkaIndividual727US$36.62
20 Dec 23BuyUS$8,348Hal BarronIndividual228US$36.62
20 Dec 23BuyUS$8,312Harry DietzIndividual227US$36.62
20 Dec 23BuyUS$8,312Anne BealIndividual227US$36.62
20 Dec 23BuyUS$64,333Charles BancroftIndividual1,757US$36.62
20 Dec 23BuyUS$8,348Elizabeth AndersonIndividual228US$36.62
20 Dec 23BuyUS$8,312Jesse GoodmanIndividual227US$36.62

Insider Trading Volume

Insider Buying: GSK insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GSK?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,520,2540.0373%
Individual Insiders3,476,4190.0852%
State or Government6,717,4270.165%
Private Companies45,842,1421.12%
Employee Share Scheme72,477,7821.78%
General Public467,790,05911.5%
Institutions3,482,675,61885.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 50.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.12%
Dodge & Cox
372,010,542US$6.3b0.06%1.99%
8.48%
BlackRock, Inc.
345,941,723US$5.9b1.97%0.09%
4.7%
The Vanguard Group, Inc.
191,755,207US$3.3b-0.51%0.05%
2.24%
State Street Global Advisors, Inc.
91,443,843US$1.6b0.41%0.06%
2.08%
Wellington Management Group LLP
84,793,263US$1.4b6.12%0.22%
2.07%
FMR LLC
84,459,667US$1.4b-7.13%0.08%
1.98%
Legal & General Investment Management Limited
80,832,617US$1.4b-1.28%0.24%
1.98%
Schroder Investment Management Limited
80,779,184US$1.4b0.32%0.82%
1.9%
Norges Bank Investment Management
77,390,644US$1.3b-1.65%0.1%
1.78%
GlaxoSmithKline Employee Trust
72,477,782US$1.2b-0.5%no data
1.63%
UBS Asset Management AG
66,643,924US$1.1b7.28%0.11%
1.24%
Mondrian Investment Partners Limited
50,764,058US$865.0m9.36%5.53%
1.2%
Silchester International Investors LLP
49,126,050US$837.1m0%3.13%
1.12%
GlaxoSmithKline plc, Shareview Client
45,842,142US$781.2m-0.84%no data
1.02%
HSBC Global Asset Management (UK) Limited
41,597,425US$708.8m0.59%0.29%
1.01%
Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm
41,054,236US$699.6m-1.91%17.66%
0.99%
Fisher Asset Management, LLC
40,570,368US$691.3m0.13%0.27%
0.88%
Aviva Investors Global Services Ltd.
35,767,094US$609.5m-10.6%0.79%
0.83%
Strategic Advisers LLC
34,050,387US$580.2m12.3%0.21%
0.82%
Columbia Management Investment Advisers, LLC
33,429,674US$569.6m1.46%0.12%
0.78%
Royal London Asset Management Ltd.
31,962,532US$544.7m5.8%0.67%
0.73%
Causeway Capital Management LLC
29,934,107US$510.1m32.7%2.13%
0.73%
PRIMECAP Management Company
29,707,510US$506.2m2.36%0.35%
0.72%
Franklin Resources, Inc.
29,376,819US$500.6m-1.75%0.17%
0.65%
Geode Capital Management, LLC
26,689,503US$454.8m6.42%0.03%